1Assmann G,Schulte H,Cullen P,et al.Assessing risk of myocardial infarction and stroke:new data from the prospective cardiovascular Münster (PROCAM) study. Eur J Clin Invest,2007,37:925-932. 被引量：1
2Sarwar N,Danesh J,Eiriksdottir G,et al.Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.Circulation,2007,115:450-458. 被引量：1
3Emerging Risk Factors Collaboration,Di Angelantonio E,Sarwar N,et al. Major lipids,apolipoproteins,and risk of vascular disease.JAMA,2009,302:1993-2000. 被引量：1
4Vine DF,Takechi R,Russell JC,et al.Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome.Atherosclerosis,2007,190:282-290. 被引量：1
6Liu L,Wen T,Zheng XY,et al.Remnant-like particles accelerate endothelial progenitor cells senescence and induce cellular dysfunction via an oxidative mechanism. Atheroeclerosis,2009,202:405-414. 被引量：1
7Keech A,Simes RJ, Barter P,et al.Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.Lancet,2005,366:1849-1861. 被引量：1
8Jialal I, Amess W, Kaur M, et al. Management of hypertriglyceridemia in the diabetic patient. Curr Diab Rep,2010,10:316-320. 被引量：1
9Miller M,Stone NJ,Ballantyne C,et al.Triglycerides and cardiovascular disease:a scientific statement from the american heart association.Circulation,2011,123:2292-2333. 被引量：1
10Chapman MJ,Ginsberg HN,Amarenco P,et al.Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of eardiovascular disease:evidence and guidance for management.Eur Heart J,2011,32:1345-1361. 被引量：1
